Pub 100-04 Medicare Claims Processing: Renal Dialysis Facility Line Item Billing Requirement for Epoetin Alfa (EPO) Submitted on End Stage Renal Disease (ESRD) Claims
Guidance that completes the implementation of end stage renal disease (ESRD) line item billing for Renal Dialysis Facilities by providing instructions required to submit line item billing EPO on ESRD claims with dates of service on or after January 1, 2008. Line item billing allows for EPO to be billed in the same manner as other separately payable drugs.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 13, 2007
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.